Delivery Order SPE2DB22D3301-SPE2DB25FY7PF
Award Date
7/9/25
Potential Completion Date
7/10/25
Potential Value
$1.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,902.14 contract is for the supply of 4559605154 - LIALDA DR 1.2 GM TABLET 120S, a prescription medication. The award has an ultimate completion date of January 17, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,049.08 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The contract is for the delivery of 120 tablets of the prescription medication LIALDA DR 1.2 GM with a completion date of February 2, 2024. This delivery order is part of Amerisourcebergen Drug Corp's larger $999,999,999.00 indefinite delivery contract with...
This federal contract award, valued at $1,573.62, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Delivery Order with a Firm Fixed Price pricing type and is set to expire on June 25, 2024. The award is for the supply of 4564987076 - LIALDA DR 1.2 GM TABLET 120S, a pharmaceutical product. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, will deliver...
This federal contract award, valued at $1,110.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. The contract covers the delivery of 4,563,239,529 units of LIALDA DR 1.2 GM TABLET 120S, a prescription...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $3,420.36 to Amerisourcebergen Drug Corporation for 120 tablets of 1.2 gm LIALDA DR, to be delivered from its Conshohocken, Pennsylvania facility by August 23, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation. The Defense Logistics Agency manages the Department of Defense's global logistics operations, including procuring and providing medical supplies to support the...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $1,238.51 firm fixed-price delivery order contract is for the supply of MESALAMINE DR 1.2 GM TABLET 120S, a pharmaceutical product. The contract has an ultimate completion date of May 28, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of MESALAMINE 800 MG DR TABLET 180S to the Defense Logistics Agency (DLA). The $11,379.36 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on January 10, 2025. The contract has an ultimate completion date of January 13, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
This is a $2,061.98 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 120 tablets of the medication Mesalamine DR 1.2 GM. The contract has an ultimate completion date of June 25, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of 180 800-milligram delayed-release mesalamine tablets. The $6,145.71 contract has an ultimate completion date of June 11, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $2,020.34 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the provision of MESALAMINE DR 1.2 GM TABLET 120S, a pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of up to...